EUVIMEDEUVIMED entdecken
Open Access

Non-anesthesiologist-administered propofol sedation for gastrointestinal endoscopy in ASA III patients: Eight-year experience

Giuliano F Bonura, Pablo Cortegoso Valdivia iD, Gabriella Frassanito, Noemi Gualandi, Paola Soriani, Federica Indulti, Valentina Zadro, Arianna Parrella, Tommaso Gabbani, Antonio Facciorusso iD, Konstantinos Triantafyllou, Mauro Manno iD

Endoscopy International Open · 12.05.2026 · 14 (CP)

DOI: 10.1055/a-2857-9602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 12.05.2026. Verfasst von Giuliano F Bonura und 11 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Digestive Endoscopy UnitAzienda USL ModenaModenaItaly. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and study aims Sedation in gastrointestinal endoscopy is widely recognized for improving patient comfort, procedure quality, and endoscopist satisfaction. Although non-anesthesiologist-administered sedation (NAS) with propofol is well established for low-risk patients (i.e. American Society of Anesthesiologist [ASA] I-II), evidence for its safety in higher-risk populations remains limited. The aim of this study was to evaluate safety of NAS with propofol in ASA III patients undergoing diagnostic gastrointestinal endoscopy. Patients and methods This observational study included ASA III patients who underwent elective gastroscopy or colonoscopy under NAS with propofol, with or without adjunctive midazolam and/or fentanyl, between 2017 and 2024. Sedation was administered by trained endoscopy personnel according to European Society of Gastrointestinal Endoscopy/European Society of Gastroenterology and Endoscopy Nurses and Associates guidelines. Anesthesia-related adverse events (ARAEs) were categorized as minor, moderate, or severe based on World Society of Intravenous Anesthesia definitions. Secondary outcomes included identification of potential risk factors for ARAEs.

Results

Among 1423 procedures (43.4% gastroscopies, 56.6% colonoscopies), overall incidence of ARAEs was 5.2% (3.9% minor, 0.9% moderate, 0.4% severe), with no tracheal intubations or deaths. Hypotension (3.6%) was the most frequent and all such events were transient and reversible. Severe ARAEs were all bradycardia, successfully treated with atropine administration. The ARAE rate was higher with propofol + midazolam (8.6%) than with propofol + fentanyl (3.7%, P = 0.04). Logistic regression analysis identified lower body mass index as the only independent predictor of ARAEs (P < 0.001).

Conclusions

NAS with propofol appears safe and feasible in ASA III patients when performed by trained staff following standardized protocols and monitoring. These findings support expanding NAS with propofol to higher-risk populations, optimizing resources and access to endoscopic care.

Schlagwörter

Stichwörter der Autor:innen

Quality and logistical aspectsQuality managementSedation and monitoringTraining

Autor:innen und Institutionen

  • Gastroenterology and Digestive Endoscopy UnitAzienda USL ModenaModenaItaly.
  • Gastroenterology and Endoscopy UnitUniversity Hospital of ParmaParmaItaly.
  • Department of Clinical ResearchUniversity of Southern DenmarkOdenseDenmark.
  • Surgical Research UnitOdense University HospitalOdenseDenmark.
  • Department Experimental MedicineUniversità del SalentoLecceItaly.
  • Second Department of Gastroenterology, Attikon University General HospitalNational and Kapodistrian University of AthensAthensGreece.

ORCID-Profile: Pablo Cortegoso Valdivia, Antonio Facciorusso, Mauro Manno

Zitieren

APA

Bonura, G. F., Cortegoso Valdivia, P., Frassanito, G., Gualandi, N., Soriani, P., Indulti, F., Zadro, V., Parrella, A., Gabbani, T., Facciorusso, A., Triantafyllou, K., & Manno, M. (2026). Non-anesthesiologist-administered propofol sedation for gastrointestinal endoscopy in ASA III patients: Eight-year experience. Endoscopy International Open, 14(CP). https://doi.org/10.1055/a-2857-9602

Vancouver

Bonura GF, Cortegoso Valdivia P, Frassanito G, Gualandi N, Soriani P, Indulti F, et al. Non-anesthesiologist-administered propofol sedation for gastrointestinal endoscopy in ASA III patients: Eight-year experience. Endoscopy International Open. 2026;14(CP). doi:10.1055/a-2857-9602

BibTeX
@article{Bonura2026,
  author = {Bonura, Giuliano F and Cortegoso Valdivia, Pablo and Frassanito, Gabriella and Gualandi, Noemi and Soriani, Paola and Indulti, Federica and Zadro, Valentina and Parrella, Arianna and Gabbani, Tommaso and Facciorusso, Antonio and Triantafyllou, Konstantinos and Manno, Mauro},
  title = {Non-anesthesiologist-administered propofol sedation for gastrointestinal endoscopy in ASA III patients: Eight-year experience},
  journal = {Endoscopy International Open},
  year = {2026},
  volume = {14},
  number = {CP},
  doi = {10.1055/a-2857-9602}
}
Kostenlos starten →